Skip to main content
Veterinary Medicines

BIOCAN PUPPY – lyophilisate and solvent for suspension for injection

Authorised
  • Canine distemper virus, strain CDVU 39, Live
  • Canine parvovirus, strain OP-I/81, Inactivated

Product identification

Medicine name:
BIOCAN PUPPY – lyophilisate and solvent for suspension for injection
Active substance:
  • Canine distemper virus, strain CDVU 39, Live
  • Canine parvovirus, strain OP-I/81, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain CDVU 39, Live
    4.20
    log10 tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain OP-I/81, Inactivated
    1024.00
    haemagglutinating units
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AH
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • BFSA
Authorisation number:
  • 0022-1461
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 26/04/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 26/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."